Foot and Mouth Disease (FMD) stands as a highly contagious viral ailment impacting cloven-hoofed creatures like cattle, pigs, sheep, and goats. Rooted in the Picornaviridae family, the FMD virus triggers symptoms like fever and blister-like sores on the tongue, mouth, and hooves, causing lameness and a decline in milk production. The virus swiftly disseminates through direct contact, contaminated equipment, or airborne transmission, carrying severe economic consequences due to trade restrictions on affected nations. Preventive strategies encompass vaccination, stringent biosecurity measures, and swift detection via surveillance. Controlling the spread necessitates culling infected animals. Although FMD doesn't typically afflict humans, its impact on global livestock industries is considerable. Ongoing global initiatives concentrate on surveillance, vaccination initiatives, and preparedness planning to effectively manage and curb the spread of Foot and Mouth Disease.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States
Title : Commensal bacteria drive B-cell lymphomagenesis in the setting of innate immunodeficiency
Ping Xie, Rutgers University, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States